The occurrence of an acute superficial phle bitis in a patient with hemophilia A is reported. The patient is a 29-year-old hemophiliac who was hospitalized because of a severe posttraumatic left knee hemarthrosis.The phlebitic changes involved the left basilic vein and appeared after 9 days of hospital stay, while the knee condition had already considerably improved. No changes in the underlying coagulation defect were present at the time of the onset of the phlebitis. During the hospital stay, besides fresh or frozen plasma, the patient was given i.v. analgesic therapy namely Novalgin, a pyrazolon derivative, and Tal-win, pentazocine lactate. It is assumed that the phlebitic changes were secondary to the administration of the compounds. The process disappeared in 3 days with no therapy.

Keywords:
Hemophilia, Phlebitis in hemophilia
This content is only available via PDF.
© 1972 S. Karger AG, Basel
1972
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.